Kidney-limited thrombotic microangiopathy in patients with SLE treated with romiplostim.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 23554039)

Published in Lupus on April 01, 2013

Authors

S Tomov1, J Lazarchick, S E Self, E T Bruner, M N Budisavljevic

Author Affiliations

1: Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.

Articles by these authors

Health care history and utilization for Atlantans who died homeless. J Med Assoc Ga (1989) 1.74

The effects of desmopressin and 6% hydroxyethyl starch on factor VIII:C. Anesth Analg (1996) 1.41

Myelodysplasia associated with Turner syndrome. J Pediatr Hematol Oncol (1996) 1.38

Subclavian venipuncture: preventable complications; report of two cases. Mayo Clin Proc (1970) 1.29

Immunoradiometric measurement of the factor VIII procoagulant antigen. J Clin Invest (1978) 1.21

Synthesis and release of factor VIII by cultured human endothelial cells. Br J Haematol (1981) 1.15

Inhibitory anti-factor V antibodies bind to the factor V C2 domain and are associated with hemorrhagic manifestations. Blood (1998) 1.08

Prospective measure of serum 3-nitrotyrosine levels in systemic lupus erythematosus: correlation with disease activity. Proc Assoc Am Physicians (2000) 1.04

Acute antibody-mediated rejection following heart transplantation. Am J Transplant (2007) 1.03

The effect of bacteremia on automated platelet measurements in neonates. Am J Clin Pathol (1990) 1.01

The properties of immune complexes formed by human antibodies to factor VIII. J Clin Invest (1977) 0.91

Pyogenic liver abscess. Mayo Clin Proc (1973) 0.91

Group-specific component (vitamin D binding protein) prevents the interaction between G-actin and profilin. Biochemistry (1986) 0.89

Prostate cancer metastatic to the peritoneum in a peritoneal dialysis patient. Perit Dial Int (2012) 0.88

Umbilical vein thrombosis at 32 weeks' gestation with delivery of a living infant. Am J Obstet Gynecol (1983) 0.88

Resistance to remnant nephropathy in the Wistar-Furth rat. J Am Soc Nephrol (1999) 0.87

Intrapleural streptokinase in experimental empyema. Am Rev Respir Dis (1993) 0.86

Evidence of accelerated platelet production and consumption in nonthrombocytopenic preeclampsia. Am J Obstet Gynecol (1986) 0.83

Plasma fibronectin levels in preeclampsia: a possible biochemical marker for vascular endothelial damage. Am J Obstet Gynecol (1984) 0.82

Prenatal diagnosis of classic hemophilia. N Engl J Med (1979) 0.82

Platelet dysfunction in Noonan's syndrome. A case with a platelet cyclooxygenase-like deficiency and chronic idiopathic thrombocytopenic purpura. Am J Clin Pathol (1991) 0.82

Acute renal artery and vein thrombosis after renal transplant, associated with a short partial thromboplastin time and factor V Leiden mutation. Ann Clin Lab Sci (2000) 0.82

Primary hepatic B-cell lymphoma of mucosa-associated lymphoid tissue. Arch Pathol Lab Med (1999) 0.81

Normal range of plasma fibrinogen. Am J Med Technol (1983) 0.81

Autologous bone marrow transplant in a patient with sickle cell disease and diffuse large B-cell lymphoma. Transplant Proc (2003) 0.81

Use of a bleeding time determination in the evaluation of unexplained hematuria. J Urol (1987) 0.81

Cyclosporine-induced hemolytic uremic syndrome and hemorrhagic colitis following renal transplantation. Clin Transplant (1999) 0.80

Acquired dysfibrinogenemia secondary to mithramycin toxicity. Am J Med Sci (1986) 0.80

Iodinated contrast media: effect of osmolarity and injection temperature on erythrocyte morphology in vitro. Acta Radiol (2008) 0.79

Mechanism of factor VIII inactivation by human antibodies. IV. Antibody binding prevents factor VIII proteolysis by thrombin. Ann Clin Lab Sci (1987) 0.78

Mean platelet volume and platelet distribution width in the neonate. Am J Pediatr Hematol Oncol (1987) 0.78

Lupus anticoagulants in children. Ann Clin Lab Sci (1988) 0.78

Platelet-associated IgG assay using flow cytometric analysis. J Immunol Methods (1986) 0.77

Elevated glucose concentrations increase factor VIIIR:Ag levels in human umbilical vein endothelial cells. Diabetes (1983) 0.77

Protein C deficiency as a cause of pulmonary embolism in the perioperative period. Anesthesiology (1991) 0.77

Destabilization of natriuretic peptide C-receptor mRNA by phorbol myristate acetate. J Am Soc Nephrol (1998) 0.77

Immunophenotypic analysis of non-Hodgkin's lymphomas. Recenti Prog Med (1990) 0.77

Acquired free protein S deficiency in children with steroid resistant nephrosis. Ann Clin Lab Sci (1996) 0.76

Systemic mast cell disease with marrow and splenic involvement associated with chronic myelomonocytic leukemia. Leuk Lymphoma (1999) 0.76

Predictive value of fibronectin levels in normotensive gravid women destined to become preeclamptic. Am J Obstet Gynecol (1986) 0.76

Viruses in posttransplant thrombotic microangiopathy. Transplantation (2001) 0.75

Platelet cross matching. Clin Lab Haematol (1993) 0.75

Alterations in von Willebrand factor antigen in premature infants with respiratory distress syndrome and chronic lung disease. Ann Clin Lab Sci (1993) 0.75

Laboratory recognition of a rare hemoglobinopathy: hemoglobins SS and SG(Philadelphia) associated with alpha-thalassemia-2. Arch Pathol Lab Med (1999) 0.75

Lymphocyte subsets in lymph node hyperplasias and B cell neoplasms as determined by fluoresceinated antibodies and flow cytometry. Ann N Y Acad Sci (1986) 0.75

Microcytotoxicity assay for platelet antibodies using fresh and frozen fluorescein-labeled target platelets. Diagn Clin Immunol (1987) 0.75

Postfiltration factor VIII and fibrinogen levels in cryoprecipitate stored at room temperature and at 1 to 6 degrees C. Transfusion (1992) 0.75

The effect of the physicochemical state of factor VIII on its interaction with human antibodies. Ann Clin Lab Sci (1984) 0.75

Factor VIII procoagulant antigen levels in normal pregnancy and preeclampsia. Ann Clin Lab Sci (1986) 0.75

The interaction of maintenance interferon with cytolytic cells in patients with multiple myeloma who responded to cytotoxic chemotherapy. Pharmacotherapy (1997) 0.75

Mechanism of factor VIII inactivation by human antibodies. III. Proteolytic cleavage of factor VIII:C and C antigen by thrombin. Ann Clin Lab Sci (1985) 0.75

CD34+ and CD33+ stem cells: predictors of hematologic recovery? Prog Clin Biol Res (1992) 0.75

The effect of lymphocytes from renal transplant patients on glomerular basement membrane sulfate uptake. Pediatr Nephrol (1995) 0.75

An unusual circulating anticoagulant in an asymptomatic child. Am J Pediatr Hematol Oncol (1985) 0.75

Hemoglobin C--G-Georgia double heterozygosity: a case report. Ann Clin Lab Sci (1993) 0.75

Detection of platelet antibodies by flow cytometric analysis. Diagn Immunol (1984) 0.75

Factor V inhibitor in a liver transplant patient associated with porcine xenoperfusion. Ann Clin Lab Sci (1998) 0.75

Spontaneous formation of an anti-S alloantibody in association with mixed connective tissue disease. Ann Clin Lab Sci (1987) 0.75

Mixed mononuclear cell cultures do not elaborate factor VIII. New Istanbul Contrib Clin Sci (1980) 0.75

Schistocytosis, aminotransferase elevation and thrombocytopenia in preeclampsia/eclampsia. J Reprod Med (1987) 0.75

Hemostatic alterations with exercise conditioning in NIDDM. Diabetes Care (1990) 0.75

Antenatal vitamin K therapy of the low-birth-weight infant. Am J Obstet Gynecol (1994) 0.75

Common variable immune deficiency syndrome associated with lupus anticoagulant. Clin Exp Rheumatol (1985) 0.75

Altered villus vessel fibronectin in preeclampsia. Am J Obstet Gynecol (1987) 0.75

The mechanism of factor VIII inactivation by human antibodies. II. The effect of factor VIII R: antigen on the rate of interaction. Ann Clin Lab Sci (1985) 0.75

Factor V inhibitor associated with immune complex formation. Arch Pathol Lab Med (1986) 0.75

Prenatal vitamin K for low birth weight infants. Int J Artif Organs (1993) 0.75

Are lymphocyte subset determinations affected by storage conditions? Diagn Immunol (1984) 0.75

Acquired von Willebrand syndrome due to an inhibitor specific for von Willebrand factor antigens. Am J Hematol (1986) 0.75

Impaired platelet function associated with parenteral nafcillin. Ann Clin Lab Sci (1990) 0.75

Mesenteric vein thrombosis secondary to protein S deficiency. Am J Gastroenterol (1999) 0.75

Passive neonatal thrombocytopenia. A case study of factors predicting the response to i.v. IgG therapy. Ann Clin Lab Sci (1989) 0.75

Acquired von Willebrand's syndrome associated with an extranodal pulmonary lymphoma. Arch Pathol Lab Med (1988) 0.75

Hairy cell leukemia and vasculitis. J Rheumatol (1981) 0.75

The role of apheresis in the support of life-threatening ITP relapse. Am J Med Sci (1987) 0.75